SARAH MICHAUD: Open Payments
NPI 1790448306 · CONCORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,583 in 78 payments from 19 companies in 2025. Trend: 2023 $1,375 · 2024 $1,504 · 2025 $1,583
Food & beverage: $1,511Education: $72
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 26 | $316 |
| Janssen Biotech, Inc. | 5 | $274 |
| UCB, Inc. | 5 | $207 |
| ABBVIE INC. | 15 | $205 |
| E.R. Squibb & Sons, L.L.C. | 5 | $93 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $69 |
| Regeneron Healthcare Solutions, Inc. | 3 | $68 |
| PFIZER INC. | 3 | $59 |
| Botanix SB Inc | 2 | $42 |
| Galderma Laboratories, L.P. | 2 | $35 |
Products named: OPZELURA, TREMFYA, Bimzelx, SKYRIZI, Sotyktu, DUPIXENT, RINVOQ, LITFULO.
Industry payments across MA — which companies pay providers there.
